Jeffrey P. Conn
Affiliations: | Vanderbilt University, Nashville, TN |
Google:
"Jeffrey Conn"Mean distance: 13.07 (cluster 6)
Parents
Sign in to add mentor| Elaine Sanders-Bush | grad student | 1982-1986 | Vanderbilt |
| Leonard K. Kaczmarek | post-doc | 1986-1988 | Yale School of Medicine |
Children
Sign in to add trainee| Kari A. Johnson | grad student | Vanderbilt | |
| Evan P. Lebois | grad student | Vanderbilt | |
| Sean P Moran | grad student | Vanderbilt | |
| Danny Winder | grad student | Emory | |
| Robert W. Gereau | grad student | 1991-1995 | Emory University School of Medicine |
| Thomas A. Macek | grad student | 2000 | Emory |
| Hazar A. Granko | grad student | 2001 | Emory |
| Richard D. Peavy | grad student | 2001 | Emory |
| Jana K. Shirey-Rice | grad student | 2010 | Vanderbilt |
| Rebecca Klar Senter | grad student | 2011-2015 | Vanderbilt |
| Tristano Pancani | post-doc | Vanderbilt | |
| Douglas J. Sheffler | post-doc | Vanderbilt | |
| Ornella Valenti | post-doc | Vanderbilt | |
| Adam G. Walker | post-doc | Vanderbilt University Medical Center | |
| Derrick L. Choi | post-doc | 2012- | Vanderbilt |
| Jessica Banko | post-doc | 2005-2006 | Vanderbilt School of Medicine |
| Nellie E. Byun | research scientist | 2010- | Vanderbilt |
Collaborators
Sign in to add collaborator| Anis Contractor | collaborator | Northwestern | |
| Morgane Thomsen | collaborator | 2009- | Vanderbilt |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dwomoh L, Rossi M, Scarpa M, et al. (2022) M muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. Science Signaling. 15: eabm3720 |
| Luessen DJ, Gallinger IM, Ferranti AS, et al. (2022) mGlu-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| Conley A, Key A, Blackford J, et al. (2020) FUNCTIONAL ACTIVITY OF THE MUSCARINIC POSITIVE ALLOSTERIC MODULATOR VU319 DURING A PHASE 1 SINGLE ASCENDING DOSE STUDY The American Journal of Geriatric Psychiatry. 28: S114-S115 |
| Russell JK, Gould RW, Bubser M, et al. (2019) P2-068: Circadian Rhythm-Dependent Effects Of M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulators On Arousal And Cognition Alzheimers & Dementia. 15 |
| Newhouse PA, Conley AC, Key AP, et al. (2019) P2-009: DEVELOPMENT OF THE MUSCARINIC CHOLINERGIC PAM VU319 FOR COGNITIVE ENHANCEMENT: PHASE 1 TESTS OF SAFETY AND TARGET ENGAGEMENT Alzheimer's & Dementia. 15: P574-P574 |
| Conley AC, Key AP, Blackford JU, et al. (2019) P1-053: COGNITIVE AND ELECTROPHYSIOLOGICAL MEASURES OF A PHASE 1 SINGLE ASCENDING DOSE STUDY OF THE MUSCARINIC POSITIVE ALLOSTERIC MODULATOR VU319 Alzheimer's & Dementia. 15: P253-P253 |
| Gogliotti R, Fisher N, Stansley B, et al. (2018) Total RNA-sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target. The Journal of Pharmacology and Experimental Therapeutics |